![\"A](\"https:\/\/wp-assets.futurism.com\/2019\/04\/mice-gene-edited-human-diseases-300x158.png\")
<\/div>Gene Hackman<\/h2>
A fascinating new Bloomberg<\/em> story<\/a> looks at the growing market for mice scientists have gene-edited to mimic human diseases ranging from prostate cancer to diabetes.<\/p> Researchers are shelling out big money for the CRISPR-modified rodents, according to Bloomberg<\/em>, sometimes paying as much as $17,000 for a pair — a medicine-disrupting development that’s projected to be a $1.59 billion industry by 2022.<\/p> Bloomberg<\/em> talked to Charles Lee, a former Harvard Medical School professor who’s using the gene-edited mice to develop new personalized cancer treatments in China.<\/p> “When you do these experiments, you want to be as close as possible to the way these tumors are growing in our bodies,” Lee told the magazine. “That’s not in a test tube or a petri dish. That’s in a living organism.”<\/p> READ MORE: <\/strong>China’s Selling Genetically-Modified Mice for $17,000 a Pair<\/a> [Bloomberg<\/i>]<\/span><\/p> More on mice:<\/strong> Scientists Give Mice “Super Vision” With Eye Injections<\/a><\/em><\/p> The post These $17,000 Mice Are Gene-Edited to Mimic Human Diseases<\/a> appeared first on Futurism<\/a>.<\/p> More: Gene Hackman A fascinating new\u00a0 Bloomberg story looks at the growing market for mice scientists have gene-edited to mimic human diseases ranging from prostate cancer to diabetes. Researchers are shelling out big money for the CRISPR-modified rodents, according to\u00a0 Bloomberg , sometimes paying as much as $17,000 for a pair\u00a0\u2014 a medicine-disrupting development that\u2019s projected to be a $1.59 billion industry by 2022. Mouse Model Bloomberg talked to Charles Lee, a former Harvard Medical School professor who\u2019s using the gene-edited mice to develop new personalized cancer treatments in China. Continue reading Mouse Model<\/h2>
These $17,000 Mice Are Gene-Edited to Mimic Human Diseases<\/a><\/p>","protected":false},"excerpt":{"rendered":"